Brodie Bruce R, Stuckey Thomas D, Hansen Charles, VerSteeg Debra S, Muncy Denise B, Moore Susan, Gupta Navin, Downey William E
LeBauer Cardiovascular Research Foundation and the Moses Cone Heart and Vascular Center, Greensboro, North Carolina, USA.
Am J Cardiol. 2005 Feb 1;95(3):343-8. doi: 10.1016/j.amjcard.2004.09.031.
ST-segment resolution (STR) is a surrogate end point in reperfusion trials of acute myocardial infarction, but there are few data regarding the optimum methods of measurement, clinical predictors, and correlation with late cardiac mortality. Consecutive patients (n = 1,005) who had acute myocardial infarction and >/=2 mm ST-segment elevation controlled with primary percutaneous coronary intervention (PCI) constituted our study group. Follow-up was obtained in 97% of patients at a median of 6.2 years. STR measured as maximum ST-segment elevation after PCI provided better discrimination of late cardiac mortality than did STR measured as percent resolution. Complete STR (<1.0 mm ST-segment elevation after PCI) was achieved in only 42% of patients. Anterior infarction, Killip's class 3 to 4, and Thrombolysis In Myocardial Infarction flow grades <2 before PCI and <3 after PCI were strong independent predictors of partial or poor STR. STR (complete [<1.0 mm] vs partial [1.0 to 2.0 mm] vs poor [>2.0 mm]) correlated with in-hospital mortality (4.0% vs 6.7% vs 11.6%, p = 0.005), reinfarction (1.4% vs 3.4% vs 6.1%, p = 0.01), and late cardiac mortality (17% vs 25% vs 44%, p <0.0001). Correlation with late mortality was stronger for nonanterior than for anterior infarction. Poor STR was a strong independent predictor of late mortality (hazard ratio 1.63, 95% confidence interval 1.06 to 2.50, p = 0.028), even after adjusting for Thrombolysis In Myocardial Infarction flow. These data support the use of STR as a simple method to stratify patients by risk after primary PCI for acute myocardial infarction and support the use of STR as a surrogate end point in reperfusion trials of acute myocardial infarction.
ST段回落(STR)是急性心肌梗死再灌注试验中的一个替代终点,但关于最佳测量方法、临床预测因素以及与晚期心脏死亡率的相关性的数据较少。连续入选的1005例急性心肌梗死且ST段抬高≥2mm并接受直接经皮冠状动脉介入治疗(PCI)的患者构成了我们的研究组。97%的患者获得了随访,随访时间中位数为6.2年。与以回落百分比测量的STR相比,以PCI后最大ST段抬高测量的STR对晚期心脏死亡率有更好的鉴别能力。仅42%的患者实现了完全STR(PCI后ST段抬高<1.0mm)。前壁梗死、Killip分级3至4级以及PCI前心肌梗死溶栓治疗血流分级<2级且PCI后<3级是部分或不良STR的强有力独立预测因素。STR(完全回落[<1.0mm] vs部分回落[1.0至2.0mm] vs不良回落[>2.0mm])与住院死亡率(4.0% vs 6.7% vs 11.6%,p = 0.005)、再梗死(1.4% vs 3.4% vs 6.1%,p = 0.01)以及晚期心脏死亡率(17% vs 25% vs 44%,p<0.0001)相关。与前壁梗死相比,非前壁梗死与晚期死亡率的相关性更强。即使在调整心肌梗死溶栓治疗血流后,不良STR仍是晚期死亡率的强有力独立预测因素(风险比1.63,95%置信区间1.06至2.50,p = 0.028)。这些数据支持将STR作为急性心肌梗死直接PCI后按风险对患者进行分层的简单方法,并支持将STR用作急性心肌梗死再灌注试验中的替代终点。